KYONG WON KANG – Trademark Portfolio

Entity Type: 01

KYONG WON KANG holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include CLOLITE and REOLITE. The owner is based in LOS ANGELES, CA.

APT 203

5057 MAPLEWOOD AVE

LOS ANGELES, CA 90004

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CLOLITE
CLOLITE
Registered 2023
REOLITE
REOLITE
Registered 2023
REOLITE
REOLITE
Registered 2021

Trademark Classifications

KYONG WON KANG's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (2 filings)

Clothing, footwear, headgear

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does KYONG WON KANG have?

KYONG WON KANG has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does KYONG WON KANG file in?

KYONG WON KANG files trademarks across 3 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 1 (Chemicals), Class 10 (Medical Apparatus). Class 25 covers clothing, footwear, headgear.

What are KYONG WON KANG's most well-known trademarks?

KYONG WON KANG's registered trademark portfolio includes well-known marks such as CLOLITE and REOLITE. These are among 3 currently registered trademarks in the portfolio.

What is KYONG WON KANG's trademark registration success rate?

KYONG WON KANG has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.